Filament Health to supply psilocybin for federally-funded psychedelics clinical trial

Mugglehead
By Natalia Buendia CalvilloNov 17, 2022, 4:33 pm196 pts
The psilocybin development firm Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) has signed a deal to supply the psychedelic found in magic mushrooms to the Centre for Addiction and Mental Health (CAMH) for the first psilocybin study funded by the Canadian government. This Thursday, the company…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Federal Bill Would ‘Effectively’ Ban All Consumable Hemp Products—’Including CBD’—Congressional Researchers Say 65

Knocking Over the Glasses 64

Texas Hemp Advocates Nearing 150,000 Signatures Urging Gov. Abbott to Veto SB 3 64

Nevada opens foster parenting to those with cannabis records 37

The Very Large and Vexing Lawsuit Re: Cannabinoid Hyperemesis Syndrome 32

MediPharm Labs announces results of annual and special meeting, contradicting Apollo’s claims 28

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.